Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00675584 · ClinicalTrials.gov registry record · Phase 3
CARE Network Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)
A Phase 3 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 278
- Enrollment target
NCT00675584 is a Phase 3 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 278 participants.
The verdict
NCT00675584, a Phase 3 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 278 participants
- Enrollment target
Study Summary
Asthma affects about 4 million children in the United States and is a leading cause of hospitalizations and school absenteeism. Continuous wheezing in very young children may develop into asthma. Low doses of inhaled corticosteroids (ICS) are commonly prescribed to treat children with particularly bad wheezing episodes. This study will compare the safety and effectiveness of low doses of ICS taken daily versus higher doses of ICS taken only during respiratory tract illnesses for toddlers with continuous wheezing or coughing illnesses.
Interventions
- DRUG Budesonide
- DRUG Placebo Budesonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2008-08 |
| Est. Completion | 2010-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00675584
The ClinicalTrials.gov registry entry for NCT00675584 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 278 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Budesonide is the first listed.
NCT00675584 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00675584 about?
NCT00675584 is a clinical study titled "CARE Network Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)". Asthma affects about 4 million children in the United States and is a leading cause of hospitalizations and school absenteeism. Continuous wheezing in very young children may develop into asthma. Low doses of inhaled corticosteroids (ICS) are commonly prescribed to treat children with particularly b...
What is the current status of trial NCT00675584?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 278 participants. The study started on 2008-08. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00675584?
The interventions under investigation include: Budesonide (DRUG), Placebo Budesonide (DRUG).
Who is sponsoring clinical trial NCT00675584?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.